Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease.
Kleedorfer
B
B
Lees
A J
AJ
Stern
G M
GM
D000286:Administration, Sublingual; D000978:Antiparkinson Agents; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007980:Levodopa / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D007980:Levodopa; C035420:levodopa methyl ester